We are back with various AI initiatives and events after the Fall Conference in Boston:
A call for speakers on AI and ML topics for our London conference. The conference will be on April 24th 2024, in the Leonardo Royal Hotel in London. If you would like to talk, please contact Vladimir Makarov as soon as reasonably possible.
Register to attend the webinar “Emerging Regulations of AI – Impact on Pharma R&D” on January 23, 2024 at 8 am PST (11 am EST, 16:00 London). Most recently both the EU and the US announced new legislation aiming to regulate the development and use of Artificial Intelligence: the EU AI Act and the President Biden Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. Our panel of experts will discuss how these legal changes may affect research and development in drug discovery. Our panelists are: Frederik van den Broek, Senior Director, Professional Services and Consulting, Elsevier; Koen Cobbaert, Senior Manager – Quality, Standards & Regulations, Philips; Sophie Ollivier, Chief Data Officer R&D, Servier; and Gideon Rosenthal, Head of Research, Data Science Group.
Register to attend the webinar “AI - the fountain of innovation, or the monster that is eating it alive?” on January 31, 2024 at 8 am PST (11 am EST, 16:00 London). In this webinar our speaker, Dr. David V. Sanker, Partner, Morgan, Lewis, and Bockius LLP, will talk about the intellectual property matters that relate to the artificial intelligence technologies. Can the United States or Europe support the advancement of beneficial AI while simultaneously constraining harmful AI? And how does AI affect intellectual property protection? Join the discussion to consider these questions and more.
View the recording of the webinar “FAIR (meta)-Data & Assay Annotation” dedicated to our FAIR Assay Annotation project. You may also enjoy this LinkedIn post by our project team member Ellen Berg.
View the recording of the webinar “GPT & Drug Discovery: Rise of Generative Models”
View the recording of the webinar “Playing FAIR with AI” by Joe Mullen, SciBite. To harness the full potential of cutting-edge technologies, it is imperative to have your house, or more specifically, your data, in order. Here, we discuss the importance of foundational data management and the role of FAIR in enabling organisations, specifically within the life sciences, are agile enough to adapt to, and make use of, state-of-the-art technologies.
View the recording of the webinar “Unpacking unstructured data: Extracting insights from neuropathological reports of Parkinson’s disease patients using Large Language Models”. Linking pathology data with molecular and clinical data allows for a deeper understanding of disease, more accurate diagnosis, and ultimately better patient treatment. Our speakers were Daniel Miller (NIH) and Oleg Stroganov (Rancho Bioscience).
The Artificial Intelligence and Machine Learning Community is a great example of the value the Pistoia Alliance delivers to its members. There has never been a more important time to collaborate as an industry, and we hope you find our CoE inspiring and informative. If you would like to find out more about the benefits of Pistoia Alliance membership and how you can get involved with all the different initiatives we run, please send an email to Membership@PistoiaAlliance.org.